CKD患者血清尿酸水平与健康结局:前瞻性队列研究
SUA与全因及CVD死亡率呈J型非线性关系,拐点分别为311.65 μmol/L和392.34 μmol/L;高于拐点时每增加50 μmol/L,全因和CVD死亡的多变量校正HR分别增加11.7%和17.0%。SUA与癌症死亡率呈负线性相关。
要点
- CKD患者SUA与全因及CVD死亡率呈J型非线性关系,拐点分别为311.65和392.34 μmol/L。
- SUA高于拐点时,每增加50 μmol/L,全因死亡多变量校正HR增加11.7%,CVD死亡增加17.0%。
- SUA与癌症死亡率呈负线性相关。
核心结论
- 维持适当的SUA浓度可能改善CKD患者的长期健康结局,全因和CVD死亡的J型拐点分别为311.65和392.34 μmol/L。
- 需进一步临床试验探究降尿酸目标。
研究设计与样本
- 前瞻性队列研究,纳入具有全国代表性的NHANES 1999-2018中6642例CKD患者。
- 采用加权限制性立方样条结合多变量校正Cox比例风险模型检验非线性关系。
主要发现
- SUA与全因死亡率呈J型非线性关系,拐点为311.65 μmol/L;高于拐点时每增加50 μmol/L,多变量校正全因死亡HR增加11.7%。
- SUA与CVD死亡率呈J型非线性关系,拐点为392.34 μmol/L;高于拐点时每增加50 μmol/L,多变量校正CVD死亡HR增加17.0%。
- SUA与癌症死亡率呈负线性相关。
临床怎么用
- 在CKD患者中可关注SUA水平与全因及CVD死亡风险的J型关系,拐点分别为311.65和392.34 μmol/L。
- 降尿酸目标尚需进一步临床试验探究。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyperuricemia is prevalent in individuals with chronic kidney disease (CKD). Elevated serum uric acid (SUA) concentrations have been considered an independent risk factor for the onset of CKD. However, the relationship between SUA concentrations and long-term health outcomes among patients with CKD remains unclear. METHODS: We performed a prospective cohort study with nationally representative sample to investigate the relationship between SUA concentrations and mortality risk including all-cause, cardiovascular disease (CVD) and cancer mortality, among patients with CKD. The weighted restricted cubic spline analyses combined with the multivariate-adjusted Cox proportional hazard models were used to test the nonlinearity of relationship. RESULTS: The 6642 patients participating in National Health and Nutrition Examination Survey 1999-2018 were enrolled. During 656 885 person-months of follow-up time, 2619 all-cause deaths were recorded, including 1030 CVD deaths and 458 cancer deaths. Our study presented J-shaped non-linear relationships between SUA concentrations and all-cause and CVD mortality with inflection points at 311.65 μmol/L and 392.34 μmol/L, respectively. When SUA concentration was higher than those inflection points, every increase of 50 μmol/L SUA was associated with 11.7% and 17.0% greater multivariable-adjusted hazard ratio of all-cause and CVD mortality, respectively. In addition, a negative linear correlation with cancer mortality was detected. CONCLUSION: These findings suggested that maintaining appropriate SUA concentrations may improve long-term health outcomes among CKD patients. The corresponding inflection points of J-shaped non-linear relationships were 311.65 and 392.34 μmol/L for all-cause and CVD mortality. Further clinical trials are required to investigate uric acid-lowering targets.
引用
- Wu S, Xue W, Yu H, et al. Serum uric acid levels and health outcomes in CKD: a prospective cohort study. Nephrol Dial Transplant. 2024. PMID: 37698875. doi:10.1093/ndt/gfad201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。